EUVIMEDDescobrir EUVIMED
Open access · CC BY-NC-ND 4.0

Structural insights into the unique recognition module between α‐synuclein peptide and nanobody

Zeyaul Islam iD, Nishant N Vaikath, Issam Hmila, Omar M A El-Agnaf, Prasanna R Kolatkar iD

Protein Science · 2024-02 · 33 (2)

DOI: 10.1002/pro.4875 ↗

At a glance

Journal article in Protein Science, published online on 2024-01-24. Written by Zeyaul Islam and 4 co-authors. Institution: Diabetes Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar. Major MEDLINE topics: Single-Domain Antibodies, Parkinson Disease. Cited 7 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NIGMS NIH HHS, Qatar Biomedical Research Institute, Hamad Bin Khalifa University.

ResumoSubjectsDados bibliográficosCiteRelated studies

Abstract (original language)

Nanobodies are single‐domain fragments of antibodies with comparable specificity and affinity to antibodies. They are emerging as versatile tools in biology due to their relatively small size. Here, we report the crystal structure of a specific nanobody Nbα‐syn01, bound to a 14 amino acid long peptide of α‐synuclein (αSyn), a 140‐residue protein whose aggregation is associated with Parkinson's disease. The complex structure exhibits a unique binding pattern where the αSyn peptide replaces the N‐terminal region of nanobody. Recognition is mediated principally by extended main chain interaction of the αSyn peptide and specificity of the interaction lies in the central 48–52 region of αSyn peptide. Structure‐guided truncation of Nbα‐syn01 shows tighter binding to αSyn peptide and improved inhibition of α‐synuclein aggregation. The structure of the truncated complex was subsequently determined and was indistinguishable to full length complex as the full‐length form had no visible electron density for the N‐terminal end. These findings reveal the molecular basis for a previously unobserved binding mode for nanobody recognition of α‐synuclein, providing an explanation for the enhanced binding, and potential for an alternate framework for structure‐based protein engineering of nanobodies to develop better diagnostic and therapeutic tools.

Subjects

MeSH terms (MEDLINE)

Single-Domain AntibodiesParkinson DiseaseHumansalpha-SynucleinPeptidesAntibodies

Author keywords

Parkinson's diseaseamyloidsnanobodynanobody-peptide complexpeptide bindingstructure determinationunique paratopesα-synuclein

Substances

alpha-SynucleinSingle-Domain AntibodiesPeptidesAntibodies

Authors and institutions

  • Diabetes Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar.
  • Neurological Disorder Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar.

ORCID profiles: Zeyaul Islam, Prasanna R Kolatkar

Funding

  • NIGMS NIH HHS
  • Qatar Biomedical Research Institute, Hamad Bin Khalifa University

Cite

APA

Islam, Z., Vaikath, N. N., Hmila, I., El-Agnaf, O. M. A., & Kolatkar, P. R. (2024). Structural insights into the unique recognition module between α‐synuclein peptide and nanobody. Protein Science, 33(2). https://doi.org/10.1002/pro.4875

Vancouver

Islam Z, Vaikath NN, Hmila I, El-Agnaf OMA, Kolatkar PR. Structural insights into the unique recognition module between α‐synuclein peptide and nanobody. Protein Science. 2024;33(2). doi:10.1002/pro.4875

BibTeX
@article{Islam2024,
  author = {Islam, Zeyaul and Vaikath, Nishant N and Hmila, Issam and El-Agnaf, Omar M A and Kolatkar, Prasanna R},
  title = {Structural insights into the unique recognition module between α‐synuclein peptide and nanobody},
  journal = {Protein Science},
  year = {2024},
  volume = {33},
  number = {2},
  doi = {10.1002/pro.4875}
}
Start for free →